Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 9
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Rodotium 162 mg/ml V/MRP/24/0022 Huvepharma EOOD, Bulgārija QJ01XQ01 pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tiamulin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Biovet AD, Bulgārija
Date of authorisation/renewal: 07-Mar-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Mar-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Mar-2024)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (07-Mar-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/24/0022-01 1 Stikla pudele, 100 ml -
Equisedan 10 mg/ml V/MRP/13/0033 Vetcare Oy, Somija QN05CM90 horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Detomidine hydrochloride
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Laboratorios SYVA S.A.U, Spānija;Tairgi Tread-Lia Baile na Sceilge Teo (Trading as Ballinskelligs Veterinary Products), Īrija
Date of authorisation/renewal: 30-Oct-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (26-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/13/0033-01 10 mg/ml 1 Stikla flakons, 10 ml -
V/MRP/13/0033-02 10 mg/ml 1 Stikla flakons, 15 ml -
Equibactin vet. - V/DCP/19/0040 Dechra Regulatory B.V., Nīderlande QJ01EW10 horses Vairāk

Medicinal product information

Pharmaceutical form: oral powder
International name (active substance): Sulfadiazine, Trimethoprim
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] 02082019LI (02-Aug-2019)
Labelling text: [PDF] 02082019M (02-Aug-2019)
Summary of product characteristics: [PDF] 02082019ZA (02-Aug-2019)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0040-01 250/50 mg 1 ABPE trauciņš, 105 g -
V/DCP/19/0040-02 250/50 mg 1 ABPE trauciņš, 210 g -
V/DCP/19/0040-03 250/50 mg 1 ABPE trauciņš, 420 g -
V/DCP/19/0040-04 250/50 mg 1 Polipropilēna trauciņš, 840 g -
V/DCP/19/0040-05 250/50 mg 10 PET/AL/PE maisiņš, 5 g -
V/DCP/19/0040-06 250/50 mg 20 PET/AL/PE maisiņš, 5 g -
V/DCP/19/0040-07 250/50 mg 28 PET/AL/PE maisiņš, 5 g -
V/DCP/19/0040-08 250/50 mg 10 PET/AL/PE maisiņš, 15 g -
V/DCP/19/0040-09 250/50 mg 20 PET/AL/PE maisiņš, 15 g -
V/DCP/19/0040-10 250/50 mg 28 PET/AL/PE maisiņš, 15 g -
V/DCP/19/0040-12 250/50 mg 10 PET/AL/PE maisiņš, 30 g -
V/DCP/19/0040-13 250/50 mg 20 PET/AL/PE maisiņš, 30 g -
V/DCP/19/0040-14 250/50 mg 28 PET/AL/PE maisiņš, 30 g -
V/DCP/19/0040-16 250/50 mg 10 PET/AL/PE maisiņš, 60 g -
V/DCP/19/0040-17 250/50 mg 20 PET/AL/PE maisiņš, 60 g -
V/DCP/19/0040-18 250/50 mg 28 PET/AL/PE maisiņš, 60 g -
V/DCP/19/0040-20 250/50 mg 10 PET/AL/PE maisiņš, 100 g -
Versiguard Rabies - V/MRP/06/1668 Zoetis Belgium S.A., Beļģija QI07AA02 ferrets; cattle; pigs; sheep; goats; horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated Rabies virus
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 21-Mar-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Sep-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Sep-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Sep-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/06/1668-01 10 Flakons, 1 deva -
V/MRP/06/1668-12 10 Flakons, 10 deva -
V/MRP/06/1668-16 1 Flakons, 1 deva -
Lineomam LC - V/MRP/17/0024 Bioveta, a.s., Čehija QJ51RF03 cattle (lactating cows) Vairāk

Medicinal product information

Pharmaceutical form: intramammary solution
International name (active substance): Lincomycin hydrohloride, Neomycin sulphate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 24-Feb-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 230221LI (24-Feb-2021)
Labelling text: [DOCX] 230221M (24-Feb-2021)
Summary of product characteristics: [DOCX] 300523ZA (31-May-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/17/0024-01 24 Injektors, 10 ml -
Profexx 50 mg/ml V/DCP/24/0025 Alfasan Nederland BV, Nīderlande QM01AE91 cattle Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande
Date of authorisation/renewal: 26-Mar-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (26-Mar-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0025-01 1 Stikla flakons, 50 ml -
V/DCP/24/0025-02 1 Stikla flakons, 100 ml -
V/DCP/24/0025-03 1 Stikla flakons, 250 ml -
Cartaxx 50 mg/ml V/DCP/24/0026 Alfasan Nederland BV, Nīderlande QM01AE91 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande
Date of authorisation/renewal: 26-Mar-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (26-Mar-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0026-01 1 Stikla flakons, 10 ml -
V/DCP/24/0026-02 1 Stikla flakons, 20 ml -
V/DCP/24/0026-03 1 Stikla flakons, 50 ml -
Nobivac Tricat Trio - V/MRP/07/1709 Intervet International B.V., Nīderlande QI06AD04 cats Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Live attenuated feline rhinotracheitis virus, strain G2620A,Live, attenuated feline calici virus,Live attenuated feline panleucopenia virus
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 07-Oct-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Jan-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Jan-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Jan-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/07/1709-01 5 Stikla flakons (kartona kastē), 1 deva -
V/MRP/07/1709-02 10 Stikla flakons (kartona kastē), 1 deva -
V/MRP/07/1709-03 25 Stikla flakons (kartona kastē), 1 deva -
V/MRP/07/1709-04 50 Stikla flakons (kartona kastē), 1 deva -
V/MRP/07/1709-05 5 Stikla flakons (plastikāta kastē), 1 deva -
V/MRP/07/1709-06 10 Stikla flakons (plastikāta kastē), 1 deva -
V/MRP/07/1709-07 25 Stikla flakons (plastikāta kastē), 1 deva -
V/MRP/07/1709-08 50 Stikla flakons (plastikāta kastē), 1 deva -
Nobivac Pi - V/MRP/22/0003 Intervet International B.V., Nīderlande QI07AD08 dogs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Canine parainfluenza virus, strain Cornell, Live
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Jan-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Jan-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (21-Jan-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/22/0003-01 5 Stikla flakons, 1 deva -
V/MRP/22/0003-02 10 Stikla flakons, 1 deva -
V/MRP/22/0003-03 25 Stikla flakons, 1 deva -
V/MRP/22/0003-04 50 Stikla flakons, 1 deva -
Oxytocin 10 IU/ml 10 IU/ml V/NRP/96/0314 Bela-pharm GmbH&Co.KG, Vācija QH01BB02 cattle; pigs; sheep; goats; horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Oxytocin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bela-pharm GmbH&Co.KG, Vācija
Date of authorisation/renewal: 07-Oct-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Feb-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Feb-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0314-01 16,6 µg/ml 1 Stikla flakons, 10 ml -
V/NRP/96/0314-02 16,6 µg/ml 1 Stikla flakons, 50 ml -
V/NRP/96/0314-03 16,6 µg/ml 1 Stikla flakons, 100 ml -
V/NRP/96/0314-04 16,6 µg/ml 5 Stikla flakons, 10 ml -
V/NRP/96/0314-05 16,6 µg/ml 6 Stikla flakons, 10 ml -
V/NRP/96/0314-06 16,6 µg/ml 10 Stikla flakons, 10 ml -
V/NRP/96/0314-07 16,6 µg/ml 12 Stikla flakons, 10 ml -
V/NRP/96/0314-08 16,6 µg/ml 6 Stikla flakons, 50 ml -
V/NRP/96/0314-09 16,6 µg/ml 12 Stikla flakons, 50 ml -
V/NRP/96/0314-10 16,6 µg/ml 6 Stikla flakons, 100 ml -
V/NRP/96/0314-11 16,6 µg/ml 12 Stikla flakons, 100 ml -
Alpramil mg V/DCP/22/0018 Alfasan Nederland BV, Nīderlande QP54AB51 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): MILBEMYCINE OXIME, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 27-May-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0018-01 1 Al/OPA/Al/PVH blisteris, 1 tablete -
V/DCP/22/0018-02 1 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/22/0018-03 1 Al/OPA/Al/PVH blisteris, 4 tablete -
V/DCP/22/0018-04 10 Al/OPA/Al/PVH blisteris, 1 tablete -
V/DCP/22/0018-05 10 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/22/0018-06 10 Al/OPA/Al/PVH blisteris, 4 tablete -
V/DCP/22/0018-07 25 Al/OPA/Al/PVH blisteris, 1 tablete -
V/DCP/22/0018-08 25 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/22/0018-09 25 Al/OPA/Al/PVH blisteris, 4 tablete -
Alpramil mg V/DCP/22/0019 Alfasan Nederland BV, Nīderlande QP54AB51 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): MILBEMYCINE OXIME, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 27-May-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0019-01 1 Al/OPA/Al/PVH blisteris, 1 tablete -
V/DCP/22/0019-02 1 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/22/0019-03 1 Al/OPA/Al/PVH blisteris, 4 tablete -
V/DCP/22/0019-04 10 Al/OPA/Al/PVH blisteris, 1 tablete -
V/DCP/22/0019-05 10 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/22/0019-06 10 Al/OPA/Al/PVH blisteris, 4 tablete -
V/DCP/22/0019-07 25 Al/OPA/Al/PVH blisteris, 1 tablete -
V/DCP/22/0019-08 25 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/22/0019-09 25 Al/OPA/Al/PVH blisteris, 4 tablete -
Alpramil mg V/DCP/22/0020 Alfasan Nederland BV, Nīderlande QP54AB51 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): MILBEMYCINE OXIME, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 27-May-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0020-01 1 Al/OPA/Al/PVH blisteris, 1 tablete -
V/DCP/22/0020-02 1 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/22/0020-03 1 Al/OPA/Al/PVH blisteris, 4 tablete -
V/DCP/22/0020-04 10 Al/OPA/Al/PVH blisteris, 1 tablete -
V/DCP/22/0020-05 10 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/22/0020-06 10 Al/OPA/Al/PVH blisteris, 4 tablete -
V/DCP/22/0020-07 25 Al/OPA/Al/PVH blisteris, 1 tablete -
V/DCP/22/0020-08 25 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/22/0020-09 25 Al/OPA/Al/PVH blisteris, 4 tablete -
Alpramil mg V/DCP/22/0021 Alfasan Nederland BV, Nīderlande QP54AB51 cats Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): MILBEMYCINE OXIME, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 27-May-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0021-01 1 alumīnija/PVC/PE/PVDC blisteris, 1 tablete -
V/DCP/22/0021-02 1 alumīnija/PVC/PE/PVDC blisteris, 2 tablete -
V/DCP/22/0021-03 1 alumīnija/PVC/PE/PVDC blisteris, 4 tablete -
V/DCP/22/0021-04 10 alumīnija/PVC/PE/PVDC blisteris, 1 tablete -
V/DCP/22/0021-05 10 alumīnija/PVC/PE/PVDC blisteris, 2 tablete -
V/DCP/22/0021-06 10 alumīnija/PVC/PE/PVDC blisteris, 4 tablete -
V/DCP/22/0021-07 25 alumīnija/PVC/PE/PVDC blisteris, 1 tablete -
V/DCP/22/0021-08 25 alumīnija/PVC/PE/PVDC blisteris, 2 tablete -
V/DCP/22/0021-09 25 alumīnija/PVC/PE/PVDC blisteris, 4 tablete -
Tulaject 100 mg/ml V/DCP/20/0059 Alivira Animal Health Limited;, Īrija QJ01FA94 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tulathromycin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release LABORATORIOS KARIZOO, S.A., Spānija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (07-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0059-01 100 mg/ml 1 Stikla flakons, 50 ml -
V/DCP/20/0059-02 100 mg/ml 1 Stikla flakons, 100 ml -
V/DCP/20/0059-03 100 mg/ml 1 Stikla flakons, 250 ml -
ReproCyc PRRS EU - V/DCP/15/0007 Boehringer Ingelheim Vetmedica GmbH, Vācija QI09AD03 pigs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Live attenuated porcine reproductive and respiratory syndrome virus, strain 94881
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Boehringer Ingelheim Pharma GmbH & Co. KG, Vācija
Date of authorisation/renewal: 28-Apr-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0007-01 1 Stikla flakons, 10 deva -
V/DCP/15/0007-02 1 Stikla flakons, 50 deva [PDF] [PDF] [DOCX]
V/DCP/15/0007-03 1 Stikla flakons, 100 deva -
V/DCP/15/0007-04 12 Stikla flakons, 10 deva -
V/DCP/15/0007-05 25 Stikla flakons, 10 deva -
V/DCP/15/0007-06 12 Stikla flakons, 50 deva -
V/DCP/15/0007-07 25 Stikla flakons, 50 deva -
V/DCP/15/0007-08 12 Stikla flakons, 100 deva -
V/DCP/15/0007-09 25 Stikla flakons, 100 deva -
Caremast vet 600 mg V/DCP/16/0004 Vetcare Oy, Somija QJ51CE09 lactating cows Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Benzylpenicillin procaine monohydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KELA N.V., Beļģija
Date of authorisation/renewal: 24-Feb-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Jul-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Jul-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (16-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/16/0004-01 600 mg 3 Polipropilēna pilnšļirce, 1 deva -
V/DCP/16/0004-02 600 mg 5 Polipropilēna pilnšļirce, 1 deva -
V/DCP/16/0004-03 600 mg 20 Polipropilēna pilnšļirce, 1 deva -
V/DCP/16/0004-04 600 mg 40 Polipropilēna pilnšļirce, 1 deva -
V/DCP/16/0004-05 600 mg 100 Polipropilēna pilnšļirce, 1 deva -
Cevac Salmovac - V/MRP/21/0074 Ceva Sante Animale', Francija QI01AE01 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for use in drinking water
International name (active substance): Salmonella enterica, subsp. enterica, serovar Enteritidis, strain 441/014 (adenine and histidine auxotrophic), Live
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija;IDT Biologika GmbH, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Aug-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Aug-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0074-01 1 Stikla flakons, 1000 deva -
V/MRP/21/0074-02 10 Stikla flakons, 1000 deva -
V/MRP/21/0074-03 1 Stikla flakons, 5000 deva [PDF] [PDF] [DOCX]
V/MRP/21/0074-04 12 Stikla flakons, 5000 deva -
V/MRP/21/0074-05 1 Stikla flakons, 2500 deva -
V/MRP/21/0074-06 10 Stikla flakons, 2500 deva -
Biocan M - V/NRP/97/0594 Bioveta, a.s., Čehija QI06AQ02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Microsporum canis, strain CCM 8211, inactivated
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 05-Jul-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/97/0594-01 10 Flakons, 1 ml -
V/NRP/97/0594-03 2 Flakons, 1 ml -
V/NRP/97/0594-05 20 Flakons, 1 ml -
V/NRP/97/0594-06 50 Flakons, 1 ml -
V/NRP/97/0594-07 100 Flakons, 1 ml -
Biocan DHPPi - V/NRP/01/1332 Bioveta, a.s., Čehija QI07AD04 dogs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Attenuated canine distemper virus,Attenuated canine parainfluenza virus,Attenuated canine contagious laryngotracheitis virus,Live attenuated Canine Parvovirus (CPV)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 27-May-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1332-01 5 Flakons, 1 ml -
V/NRP/01/1332-02 10 Flakons, 1 ml -
V/NRP/01/1332-03 50 Flakons, 1 ml -

3082 records

© Food and veterinary service · 2026 Cookies policy